Literature DB >> 13460368

A serum factor in lupus erythematosus with affinity for tissue nuclei.

E J HOLBOROW, D M WEIR, G D JOHNSON.   

Abstract

Entities:  

Keywords:  LUPUS ERYTHEMATOSUS, DISSEMINATED

Mesh：

Year:  1957        PMID： 13460368      PMCID： PMC1962253          DOI： 10.1136/bmj.2.5047.732

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  5 in total

1.  Preparation of antiglobulin sera.

Authors:  F MILGROM; T LUSZCZYNSKI; S DUBISKI
Journal:  Nature       Date:  1956-02-18       Impact factor: 49.962

2.  Further cytochemical studies in systemic lupus erythematosus.

Authors:  B GUEFT; A LAUFER
Journal:  AMA Arch Pathol       Date:  1954-03

3.  Some supravital observations on the L.E. phenomenon.

Authors:  R J ROHN; W H BOND
Journal:  Am J Med       Date:  1952-04       Impact factor: 4.965

4.  The L.E. (lupus erythematosus) cell; clinical and chemical studies.

Authors:  S L LEE; S R MICHAEL; I L VURAL
Journal:  Am J Med       Date:  1951-04       Impact factor: 4.965

5.  Role of gamma globulins in pathogenesis of renal lesions in systemic lupus erythematosus and chronic membranous glomerulonephritis, with an observation on the lupus erythematosus cell reaction.

Authors:  R C MELLORS; L G ORTEGA; H R HOLMAN
Journal:  J Exp Med       Date:  1957-08-01       Impact factor: 14.307
  5 in total
  68 in total

1.  IMMUNOFLUORESCENT STUDIES ON THE OCCURRENCE OF ANTINUCLEAR FACTOR IN NORMAL HUMAN SERUM.

Authors:  R J LAFFIN; W A BARDAWIL; W N PACHAS; J S MCCARTHY
Journal:  Am J Pathol       Date:  1964-09       Impact factor: 4.307

2.  ANTINUCLEAR FACTOR IN RHEUMATOID ARTHRITIS, ITS INCIDENCE AND CLINICAL SIGNIFICANCE.

Authors:  D J WARD; G D JOHNSON; E J HOLBOROW
Journal:  Ann Rheum Dis       Date:  1964-07       Impact factor: 19.103

3.  Incidence of haemagglutinating and complement-fixing antibodies.

Authors:  G L ASHERSON; O BROBERGER
Journal:  Br Med J       Date:  1961-05-20

4.  SEROLOGICAL ABNORMALITIES IN PATIENTS WITH LIVER DISEASE.

Authors:  I A BOUCHIER; K RHODES; S SHERLOCK
Journal:  Br Med J       Date:  1964-03-07

5.  COMPARATIVE STUDY FOR THE DETECTION OF ANTINUCLEAR FACTORS WITH THE FLUORESCENT ANTIBODY TECHNIQUE.

Authors:  W HIJMANS; H R SCHUIT; E MANDEMA; R L NIENHUIS; T E FELTKAMP; E J HOLBOROW; G D JOHNSON
Journal:  Ann Rheum Dis       Date:  1964-01       Impact factor: 19.103

6.  ARTHRITIC MANIFESTATIONS IN REGIONAL ENTERITIS.

Authors:  B M ANSELL; R A WIGLEY
Journal:  Ann Rheum Dis       Date:  1964-01       Impact factor: 19.103

7.  LYSOSOMAL ACTIVATION IN RELATION TO CONNECTIVE TISSUE DISEASE.

Authors:  L WEISS; J T DINGLE
Journal:  Ann Rheum Dis       Date:  1964-01       Impact factor: 19.103

8.  SLOWLY SEDIMENTING MERCAPTOETHANOL-RESISTANT ANTINUCLEAR FACTORS RELATED ANTIGENICALLY TO M IMMUNOGLOBULINS (GAMMA-1M-GLOBULIN) IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS.

Authors:  N F ROTHFIELD; B FRANGIONE; E C FRANKLIN
Journal:  J Clin Invest       Date:  1965-01       Impact factor: 14.808

9.  PERIPHERAL NEUROPATHY IN RHEUMATOID ARTHRITIS.

Authors:  C A PALLIS; J T SCOTT
Journal:  Br Med J       Date:  1965-05-01

10.  Comparison between the latex nucleoprotein test and the fluorescent method for the demonstration of antinuclear factor.

Authors:  R BARNES; D CARMICHAEL; G D JOHNSON
Journal:  Ann Rheum Dis       Date:  1962-09       Impact factor: 19.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.